CohenJ.I., DavenportD.S., StewartJ.A., DeitchmanS., HilliardJ.K., ChapmanL.E., & the B Virus Working Group. (2002). Recommendations for prevention of and therapy for exposure to B virus (Cercopithecine Herpesvirus 1). Clinical Infectious Diseases, 35(10), 1191–1203.
2.
Fatal Cercopithecine herpesvirus 1 (B virus) infection following a mucocutaneous exposure and interim recommendations for worker protection. (1998, December 18). MMWR, 47(49), 1073–1076, 1083.
3.
Guidelines for prevention for Herpesvirus simiae (B virus) infection in monkey handlers. (1987, October 23). MMWR, 36(41), 680–682, 687–689.
4.
HilliardJ. (1996). Strategies of managing macaque monkeys and Herpes virus simiae (B-virus). Proceedings of the 4th National Symposium on Biosafety. Retrieved June 13, 2005, from the Centers for Disease Control and Prevention Website: www.cdc.gov/od/ohs/sympsium/sympl21.htm
5.
HuffJ.L., & BarryP.A. (2003). B-Virus (Cercopithecine herpesvirus 1) infection in humans and macaques: Potential for zoonotic disease. Emerging Infectious Disease, 9(2), 246–250.
6.
National Institute of Occupational Safety and Health (NIOSH). (1999). Hazard ID: Cercopithecine herpesvirus 1 (B Virus) infection resulting from ocular exposure. Retrieved June 4, 2005, from www.cdc.gov/niosh/hid5.html
7.
National Institute of Occupational Safety and Health (NIOSH). (2001). Eye safety emergency response and disaster recovery. Retrieved July 28, 2005, from www.cdc.gov/niosh/eyesafe.html
8.
WeberD.J., & RutalaW.A. (2001). Risks and prevention of nosocomial transmission of rare zoonotic diseases. Clinical Infectious Diseases, 32(3), 446–456.
